Inhibitory Effect of GST-hS100A2 Fusion Protein on Human Colorectal Carcinoma HCT116 and SW480 Cells

XU Lan-lan,YOU Li,GUO Yuan-yuan,ZOU Zheng-yu,LI Yu-ye,SUN Shuang-shuang,LUO Jin-yong,ZHOU Lan
DOI: https://doi.org/10.13200/j.cjb.2011.07.32.xull.025
2011-01-01
Abstract:Objective To investigate the inhibitory effect of fusion protein GST-hS100A2 on human colorectal carcinoma HCT-116 and SW480 cells.Methods Recombinant plasmids pGST-moluc-hS100A2 and pGST-moluc were transformed to E.coli BL21(DE3) for expression under induction of IPTG.The expressed products were identified by Western blot,then purified with Glutathion-Sepharose 4B beads.HCT116 and SW480 cells were treated with the prepared GST-hS100A2 fusion protein,using those treated with GST and those untreated as controls,and determined for proliferative activity by MTT method,for apoptosis by Hochest33258 staining,for cell cycle by flow cytometry,for migration ability by wound healing assay,and for invasion ability by Transwell test.Results GST-hS100A2 showed dose-and time-dependent inhibitory effect on the proliferation of HCT116 and SW480 cells.Meanwhile,the fusion protein significantly promoted the apoptosis and inhibited the invasion ability of both HCT116 and SW480 cells,while arrested the cell cycle and inhibited the migration of HCT116 cells.Conclusion GST-hS100A2 showed a certain inhibitory effect on HCT116 and SW480 cells and might be used as a new target for molecular therapy of colorectal carcinoma.
What problem does this paper attempt to address?